Shikari® (S-AIR) Anti-Infliximab biosimilar ELISA

Enzyme immunoassay for the qualitative determination of antibodies to infliximab-biosimilar (Remsima®) in serum and plasma.

This kit has been especially developed for the qualitative antibodies to infliximab-biosimilar (Remsima®) in serum and plasma samples

Infliximab (Remsima®) was associated to the development of anti- Infliximab antibodies, even some were reported to be neutralizing, in various percentages of patients during therapy with the drug Remsima®. This might lead to severe complications.This kit can be efficiently used for monitoring anti- Infliximab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti- Infliximab antibodies.

All SHIKARI® ELISA kits are suitable for biosimilar work.